N-acylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway
US9073835B2 · kind B2 · utility
2Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 16, 2009 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Dec 5, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D235/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.